Sinovac Biotech said on Saturday that its unit's COVID-19 vaccine has been formally approved for use by the general public by China's medical products regulator.
It marks the second COVID-19 vaccine green-lighted for public use in China, after a shot developed by a Beijing institute affiliated to state-owned China National Pharmaceutical Group (Sinopharm) was approved in December.
Prior to the approvals, both vaccines have already been used in China's vaccination program mainly targeting key groups deemed to be at higher risk of exposure to the virus.
Indonesia, Turkey, Brazil, Chile, Colombia, Uruguay, and Laos have granted emergency authorizations for the CoronaVac vaccine developed by Sinovac Life Sciences, Sinovac said in a news release.
The approval is based on the two-month results from late-stage clinical trials overseas, from which the final analysis data has not yet been obtained, Sinovac said.
Israel is poised to send troops into Rafah, the Gazan city it sees as the last bastion of Hamas, Israeli media reported on Wednesday, saying preparations were under way to evacuate war-displaced Palestinian civilians who have been sheltering there.
Former Japanese Prime Minister Taro Aso, a senior figure in the country's ruling party, met with Donald Trump on Tuesday, becoming the latest US ally seeking to establish ties with the Republican presidential candidate.
Russian missiles damaged residential buildings and injured six people in Ukraine's second-largest city, Kharkiv, early on Wednesday, Governor Oleh Synehubov said on Telegram.
Five migrants died in an attempt to cross the English Channel from France to Britain in an overcrowded small boat on Tuesday, hours after Britain passed a bill to deport asylum seekers to Rwanda in a move to deter the dangerous journeys.
Israel bombarded northern Gaza overnight in some of the heaviest shelling in weeks, causing panic amongst residents and flattening neighbourhoods in an area from which the Israeli army had previously down its troops, residents said on Tuesday.